Related Experiment Video
Updated: Jun 13, 2026
10:49
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
Application of immunotherapy in pediatric leukemia
1Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Room 1W-3750, 9000 Rockville Pike, MSC-1104, Bethesda, MD 20892, USA. waynea@mail.nih.gov
Current Hematologic Malignancy Reports
|April 29, 2010
Summary
New immunotherapies show promise for treating childhood leukemia, offering hope beyond current toxic treatments and improving outcomes after relapse. Further research is ongoing to define optimal approaches.
Area of Science:
- Pediatric Oncology
- Immunotherapy
- Hematologic Malignancies
Background:
- Current leukemia treatments in children have significant toxicities.
- Prognosis remains poor for pediatric leukemia patients experiencing relapse.
- Existing therapies face challenges with treatment resistance.
Purpose of the Study:
- To explore novel immunotherapy approaches for pediatric leukemia.
- To address limitations of current standard therapies.
- To investigate immune-based strategies for improved outcomes.
Main Methods:
- Review of existing literature on immunotherapy in pediatric leukemia.
- Analysis of graft-versus-leukemia effects from stem cell transplantation.
- Examination of ongoing clinical trials for novel immunotherapies.
Main Results:
- Immunotherapy demonstrates potential efficacy in treating childhood leukemia.
- Allogeneic stem cell transplantation highlights the power of immune-based effects.
- Early efforts in applying immunotherapy show encouraging signs.
Conclusions:
- Immunotherapy represents a promising avenue for pediatric leukemia treatment.
- Further research is crucial to optimize immunotherapy reagents, methods, and regimens.
- Ongoing clinical trials are vital for advancing these novel treatments.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...